Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hammerer

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|March 2, 2005
Discordance analysis characteristics as a new method to compare the diagnostic accuracy of tests: example of complexed versus total prostate-specific antigenThomas Keller, Hermann Butz, Michael Lein, et al.
Urologia Internationalis|August 28, 2020
Elastography Targeted Prostate Biopsy in Patients under Active SurveillanceTobias Steinwender, Lukas Manka, Mircea Grindei, et al.
World Journal of Urology|April 11, 2015
Controversial evidence for the use of HistoScanning™ in the detection of prostate cancerJonas Schiffmann, Lukas Manka, Katharina Boehm, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.
Biomedicines|September 23, 2022
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early SalvageDaniel Wegener, Daniel M Aebersold, Marc-Oliver Grimm, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 18, 2012
Can we predict urinary stone composition based on an analysis of microelement concentration in the hair and urine?Marcin Słojewski, Krzysztof Safranow, Katarzyna Jakubowska, et al.
BJU International|September 13, 2016
Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' studyRalf-Dieter Hofheinz, Carsten Lange, Thorsten Ecke, et al.
Urologia Internationalis|May 9, 2021
68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate CancerDaniela Kopp, Johannes Kopp, Eugen Bernhardt, et al.
World Journal of Urology|July 29, 2015
True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical effortsJonas Schiffmann, Gisa Mehring, Pierre Tennstedt, et al.
Aktuelle Urologie|June 1, 2021
[Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance]Marie Christine Hupe, Marten Müller, Julian Peter Struck, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|March 2, 2005
Discordance analysis characteristics as a new method to compare the diagnostic accuracy of tests: example of complexed versus total prostate-specific antigenThomas Keller, Hermann Butz, Michael Lein, et al.
Urologia Internationalis|August 28, 2020
Elastography Targeted Prostate Biopsy in Patients under Active SurveillanceTobias Steinwender, Lukas Manka, Mircea Grindei, et al.
World Journal of Urology|April 11, 2015
Controversial evidence for the use of HistoScanning™ in the detection of prostate cancerJonas Schiffmann, Lukas Manka, Katharina Boehm, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.
Biomedicines|September 23, 2022
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early SalvageDaniel Wegener, Daniel M Aebersold, Marc-Oliver Grimm, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|December 18, 2012
Can we predict urinary stone composition based on an analysis of microelement concentration in the hair and urine?Marcin Słojewski, Krzysztof Safranow, Katarzyna Jakubowska, et al.
BJU International|September 13, 2016
Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' studyRalf-Dieter Hofheinz, Carsten Lange, Thorsten Ecke, et al.
Urologia Internationalis|May 9, 2021
68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate CancerDaniela Kopp, Johannes Kopp, Eugen Bernhardt, et al.
World Journal of Urology|July 29, 2015
True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical effortsJonas Schiffmann, Gisa Mehring, Pierre Tennstedt, et al.
Aktuelle Urologie|June 1, 2021
[Osteoprotection in the management of metastatic prostate cancer: real-world data from Germany and decision guidance]Marie Christine Hupe, Marten Müller, Julian Peter Struck, et al.
Pageof 6